Inventor · disambiguated record
Eileen Elliott Mueller
Also filed as: MUELLER EILEEN E · MUELLER EILEEN ELLIOTT
13 granted patents·2 pending applications·2,280 citations·filing 1995–2014
95Inventor score
Top patents by PatentIndex Score
15 records- 0198US7824679B2Human monoclonal antibodies to CTLA-4AMGEN FREMONT INC·Filed 2007·Granted Nov 2, 2010·87 cites·19 claims
- 0298US7411057B2Nucleic acids encoding human monoclonal antibodies to CTLA-4AMGEN FREMONT INC·Filed 2005·Granted Aug 12, 2008·87 cites·38 claims
- 0398US7132281B2Methods and host cells for producing human monoclonal antibodies to CTLA-4PFIZER·Filed 2004·Granted Nov 7, 2006·220 cites·262 claims
- 0498US7109003B2Methods for expressing and recovering human monoclonal antibodies to CTLA-4PFIZER·Filed 2003·Granted Sep 19, 2006·287 cites·101 claims
- 0598US6682736B1Human monoclonal antibodies to CTLA-4ABGENIX INC·Filed 1999·Granted Jan 27, 2004·776 cites·104 claims
- 0697US8883984B2Human monoclonal antibodies to CTLA-4AMGEN FREMONT INC·Filed 2013·Granted Nov 11, 2014·38 cites·24 claims
- 0797US8491895B2Methods of treating cancer with human monoclonal antibodies to CTLA-4HANSON DOUGLAS CHARLES·Filed 2012·Granted Jul 23, 2013·99 cites·20 claims
- 0897US8143379B2Human monoclonal antibodies to CTLA-4HANSON DOUGLAS CHARLES·Filed 2007·Granted Mar 27, 2012·121 cites·22 claims
- 0997US7807797B2Human monoclonal antibodies to CTLA-4AMGEN FREMONT INC·Filed 2007·Granted Oct 5, 2010·76 cites·25 claims
- 1096US6355245B1C5-specific antibodies for the treatment of inflammatory diseasesALEXION PHARMA INC·Filed 1995·Granted Mar 12, 2002·465 cites·23 claims
- 1191US9963508B2Human monoclonal antibodies to CTLA-4AMGEN FREMONT INC·Filed 2014·Granted May 8, 2018·6 cites·13 claims
- 1283US7101869B22,4-diaminopyrimidine compounds useful as immunosuppressantsPFIZER·Filed 2002·Granted Sep 5, 2006·18 cites·13 claims
- 1348US2003086930A1Uses of anti-CTLA-4 antibodiesFiled 2002·Application pending·0 cites
- 1442US2005226875A1Uses of anti-CTLA-4 antibodiesPFIZER·Filed 2005·Application pending·0 cites
- 1526US7041503B2Modified myelin basic protein moleculesALEXION PHARMA INC·Filed 1995·Granted May 9, 2006·0 cites·19 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →